Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy
NCT05673850
·
clinicaltrials.gov ↗
COMPLETED
Status
518
Enrollment
OTHER
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
NET or NCT
Sponsor
Peking University